Literature DB >> 9521132

The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays.

W Cleare1, A Casadevall.   

Abstract

Cryptococcus neoformans var. neoformans strains have historically been divided into serotypes A and D on the basis of reactivity with rabbit sera. Previously, we noted that two murine immunoglobulin M monoclonal antibodies (MAbs) to the capsular glucuronoxylomannan produced different indirect immunofluorescence (IF) patterns, described as annular and punctate, when bound to C. neoformans cells from different strains. In this study, we examined the reactivity of these two MAbs, known as 12A1 and 13F1, with 20 C. neoformans var. neoformans strains, of which 13 were serotype A and 7 were serotype D. For all strains, MAb binding was studied by IF and agglutination assays. In addition, we blindly tested the IF patterns of 22 C. neoformans var. neoformans strains. For selected strains, MAb binding was studied by flow cytometry (FACScan) and phagocytosis assays. The epitopes recognized by MAbs 12A1 and 13F1 were found in all of the strains. MAb 12A1 binding produced an annular IF pattern with all of the strains, irrespective of the serotype classification. MAb 13F1 binding produced annular binding with all of the serotype A strains and punctate binding with 19 of 20 serotype D strains. In general, the punctate IF pattern was associated with lower fluorescence intensity, a requirement for higher antibody concentrations to produce yeast cell agglutination, and lower opsonic efficacy. Our results provide strong support for the existing classification of two serological types for strains assigned to variety neoformans and indicate qualitative and quantitative antigenic differences among serotype A and D strains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521132      PMCID: PMC121347          DOI: 10.1128/CDLI.5.2.125-129.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  24 in total

1.  Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.

Authors:  A Casadevall; J Mukherjee; S J Devi; R Schneerson; J B Robbins; M D Scharff
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

2.  The indirect fluorescent antibody test for the detection of antibody in human cryptococcal disease.

Authors:  R A Vogel
Journal:  J Infect Dis       Date:  1966-12       Impact factor: 5.226

3.  Antigenic variation within serotypes of Cryptococcus neoformans detected by monoclonal antibodies specific for the capsular polysaccharide.

Authors:  C Spiropulu; R A Eppard; E Otteson; T R Kozel
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

4.  Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.

Authors:  F Dromer; J Salamero; A Contrepois; C Carbon; P Yeni
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

5.  Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.

Authors:  F Dromer; E Gueho; O Ronin; B Dupont
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  Monoclonal antibody based ELISAs for cryptococcal polysaccharide.

Authors:  A Casadevall; J Mukherjee; M D Scharff
Journal:  J Immunol Methods       Date:  1992-09-18       Impact factor: 2.303

7.  Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.

Authors:  F Todaro-Luck; E Reiss; R Cherniak; L Kaufman
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

8.  The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies.

Authors:  A Casadevall; M D Scharff
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

9.  Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane.

Authors:  F M Griffin; J A Griffin; J E Leider; S C Silverstein
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization.

Authors:  J Mukherjee; A Casadevall; M D Scharff
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more
  24 in total

1.  Monoclonal antibody 13F1 produces annular immunofluorescence patterns on Cryptococcus neoformans serotype AD isolates.

Authors:  W Cleare; M E Brandt; A Casadevall
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Role of the Apt1 protein in polysaccharide secretion by Cryptococcus neoformans.

Authors:  Juliana Rizzo; Débora L Oliveira; Luna S Joffe; Guanggan Hu; Felipe Gazos-Lopes; Fernanda L Fonseca; Igor C Almeida; Susana Frases; James W Kronstad; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2013-12-13

3.  The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response.

Authors:  Oscar Zaragoza; Mauricio Alvarez; Andrew Telzak; Johanna Rivera; Arturo Casadevall
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

4.  Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in India.

Authors:  Piyali Mandal; Uma Banerjee; Arturo Casadevall; Joshua D Nosanchuk
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure.

Authors:  B C Fries; D L Goldman; R Cherniak; R Ju; A Casadevall
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages.

Authors:  J N Steenbergen; H A Shuman; A Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

7.  Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies.

Authors:  A Nakouzi; P Valadon; J Nosanchuk; N Green; A Casadevall
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

8.  Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates.

Authors:  S P Franzot; I F Salkin; A Casadevall
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.

Authors:  A Casadevall; W Cleare; M Feldmesser; A Glatman-Freedman; D L Goldman; T R Kozel; N Lendvai; J Mukherjee; L A Pirofski; J Rivera; A L Rosas; M D Scharff; P Valadon; K Westin; Z Zhong
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

10.  Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct.

Authors:  Priscila C Albuquerque; Fernanda L Fonseca; Fabianno F Dutra; Marcelo T Bozza; Susana Frases; Arturo Casadevall; Marcio L Rodrigues
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.